Quick Answer
Moderna, Inc. reported Net Income of -$2.82 billion for fiscal year 2025.
Moderna, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.82B | +20.8% |
| 2024 | -$3.56B | +24.5% |
| 2023 | -$4.71B | -156.4% |
| 2022 | $8.36B | -31.5% |
| 2021 | $12.20B | +1733.5% |
| 2020 | -$747.00M | -45.3% |
| 2019 | -$514.00M | -33.6% |
| 2018 | -$384.73M | -50.3% |
| 2017 | -$255.92M | -18.4% |
| 2016 | -$216.21M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$200.00M | -1638.5% | +75.8% |
| June 30, 2025 | -$825.00M | +35.5% | +15.0% |
| March 31, 2025 | -$971.00M | +17.4% | -7569.2% |
| September 30, 2024 | $13.00M | +100.4% | +101.0% |
| June 30, 2024 | -$1.28B | +7.3% | -8.9% |
| March 31, 2024 | -$1.18B | -1587.3% | +67.6% |
| September 30, 2023 | -$3.63B | -448.0% | -163.0% |
| June 30, 2023 | -$1.38B | -162.8% | -1846.8% |
- Moderna, Inc. showed an increase of +20.8% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Moderna, Inc.’s net income has declined by 1205.2% (from -$216.21 million to -$2.82 billion).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: